ENO2 and glioblastoma: ENO1, an isoform of the glycolytic gene enolase generating phosphoenolpyruvate (PEP), is deleted in GBM, and ENO2 silencing selectively inhibits growth, survival and tumorigenic potential of ENO1-deleted GBM cells [45].